(R)-3-oxo-4-(2-oxo-2-((tetrahydrofuran-2-yl)methylamino)ethyl)-N-p-tolyl-3,4-dihydroquinoxaline-1(2H)-carboxamide

ID: ALA4476136

Chembl Id: CHEMBL4476136

PubChem CID: 95075245

Max Phase: Preclinical

Molecular Formula: C23H26N4O4

Molecular Weight: 422.49

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)N2CC(=O)N(CC(=O)NC[C@H]3CCCO3)c3ccccc32)cc1

Standard InChI:  InChI=1S/C23H26N4O4/c1-16-8-10-17(11-9-16)25-23(30)27-15-22(29)26(19-6-2-3-7-20(19)27)14-21(28)24-13-18-5-4-12-31-18/h2-3,6-11,18H,4-5,12-15H2,1H3,(H,24,28)(H,25,30)/t18-/m1/s1

Standard InChI Key:  FOKISOBNPXQURL-GOSISDBHSA-N

Associated Targets(non-human)

botE Botulinum neurotoxin type E (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 422.49Molecular Weight (Monoisotopic): 422.1954AlogP: 2.68#Rotatable Bonds: 5
Polar Surface Area: 90.98Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.91CX Basic pKa: CX LogP: 1.61CX LogD: 1.61
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.78Np Likeness Score: -1.52

References

1. Zhou Y, McGillick BE, Teng YG, Haranahalli K, Ojima I, Swaminathan S, Rizzo RC..  (2016)  Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity.,  24  (20): [PMID:27543389] [10.1016/j.bmc.2016.07.031]

Source